MUC5B promoter polymorphism and interstitial lung abnormalities.
about
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyUnderstanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed LungsMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung diseaseMolecular biomarkers in idiopathic pulmonary fibrosisGenetic susceptibility and pulmonary fibrosisGenome-wide association study of subclinical interstitial lung disease in MESA.Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Genetics and early detection in idiopathic pulmonary fibrosisSequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associationsThe MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.Anterior Mediastinal Masses in the Framingham Heart Study: Prevalence and CT Image Characteristics.Update in diffuse parenchymal lung disease, 2013Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course.Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalitiesDetection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.Incorporating genetics into the identification and treatment of Idiopathic Pulmonary FibrosisA comparison of visual and quantitative methods to identify interstitial lung abnormalities.MUC5B and Idiopathic Pulmonary Fibrosis.Association Between Interstitial Lung Abnormalities and All-Cause MortalityPulmonary cysts identified on chest CT: are they part of aging change or of clinical significance?CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site PolymorphismGalectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.Potential Metabolic Biomarkers to Identify Interstitial Lung AbnormalitiesAssociation Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis?IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.Chlorambucil-induced acute interstitial pneumonitis.Epigenetics of idiopathic pulmonary fibrosis.Role of genetics in lung transplant complications.Facts and promises on lung biomarkers in interstitial lung diseases.Imaging approaches to understand disease complexity: Chronic Obstructive Pulmonary Disease as a clinical model.An Ounce of Prevention… Will This Be the Future for IPF?Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis.
P2860
Q26776473-A3D388B8-29EF-4ED0-BDB0-99F56D4EB51EQ26779192-64915A02-75E8-44C2-8847-767DE0FDF4DCQ26864836-BB40025C-D1B6-4C8B-8F67-4A86CACEB553Q26998459-1E0272A7-9304-477F-BD77-611C6E11D22BQ27014138-DA004DFF-1F08-48B4-B9E2-0F34EA97903AQ27025340-422668A8-515C-4978-9655-339FBED31DD9Q28243802-D25D7857-51A5-4177-94A8-26BEEF51ECBAQ30252379-8086807F-79EE-42AD-BE46-E6A910D72923Q33600748-2D51043F-16BB-4DDB-B691-2F955E98AD8FQ33956830-13817739-1025-4E97-9F37-DB6C40FE4052Q34479395-0716B6DA-B03B-4D68-B3CE-9F6B72541CF9Q34692137-93E3FCD8-0F7A-44A2-BB72-EC1682E6FEC9Q35041524-C8CA3130-AB8F-46E7-B2F1-FBD1C7648EFFQ35094671-8B4274C6-9BED-492A-8F65-B811B12B6476Q35153423-1AAF7057-E486-4B8B-8127-94FEA3FC569DQ35153490-B69A8DA4-1593-4B37-B80C-D0B425EB9EFAQ35239965-65E802BF-6A8C-440C-9992-CE4604ED1809Q35418456-A22FAAC2-BEB0-43D7-BC07-6526707EB00AQ35668528-5313DB28-C448-4ED9-9206-BC62B56EB273Q35766847-AE14F705-AAD6-44FB-BD9C-8A5F1FB33FF0Q35786160-90805563-4E14-41D9-BB53-110808F01254Q35826595-11CC9368-0EFC-4E95-9B48-6E641DACA10EQ36490141-35C65E81-C8AF-409C-AE2E-91410E2445EEQ36790758-B4E822CE-F2F7-4D32-AC50-529CB923729DQ36844372-42EDDD1A-1293-4190-8CF2-335A9F71B36DQ37094624-14465543-8A6D-413C-B98E-750DA377F2C1Q37125501-9E455D85-23AA-4556-B885-D8D969C33975Q37134683-50843762-9B65-4B88-9346-3BCC2D2743F8Q37149994-7CFD2E7A-2EBE-427B-A4AC-A21C0EF7FE7DQ37559937-9DD3E4B3-AA23-4136-85A5-501B24C19934Q37563857-9A170545-3845-4E33-BDE1-156CBF7F9156Q37698325-4FFC0D38-250F-4509-92D3-9928186A0C3EQ38181073-AB98A640-21E4-4CA4-9369-89744BE9EA63Q38202645-21120094-3F99-4B44-B454-365C92277528Q38205635-556DC22F-BE1A-4F26-ADD5-79FDE92E4888Q38376217-C0FB0339-76A3-4F09-9650-89E434424F2AQ38543042-FF7FAC81-2D5B-42D9-8C04-66EA541C3A5EQ38656653-C750196C-3379-4C68-8D2A-597F87D91D7FQ38669356-0EFD18F7-EB12-4C49-A21D-8DD96B859873Q38751135-1AA91455-6070-428E-BD0E-FE12B3226A55
P2860
MUC5B promoter polymorphism and interstitial lung abnormalities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MUC5B promoter polymorphism and interstitial lung abnormalities.
@en
MUC5B promoter polymorphism and interstitial lung abnormalities.
@nl
type
label
MUC5B promoter polymorphism and interstitial lung abnormalities.
@en
MUC5B promoter polymorphism and interstitial lung abnormalities.
@nl
prefLabel
MUC5B promoter polymorphism and interstitial lung abnormalities.
@en
MUC5B promoter polymorphism and interstitial lung abnormalities.
@nl
P2093
P2860
P50
P356
P1476
MUC5B promoter polymorphism and interstitial lung abnormalities.
@en
P2093
David A Schwartz
Elissa Murphy
Gary M Hunninghake
George R Washko
Hiroto Hatabu
Ivan O Rosas
James C Ross
James E Loyd
Mark P Steele
Marvin I Schwarz
P2860
P304
P356
10.1056/NEJMOA1216076
P407
P577
2013-05-21T00:00:00Z